Visterra, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A (NCT03040141) | Visterra, Inc. | 2018-01-03 |
| Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A (NCT02989194) | Visterra, Inc. | 2017-01-06 |
| Influenza Challenge Study of VIS410 in Healthy Volunteers (NCT02468115) | Visterra, Inc. | 2015-05-01 |
| A Study of VIS410 to Assess Safety and Pharmacokinetics (NCT02045472) | Visterra, Inc. | 2014-09-01 |
Track Visterra, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.